Skip to search formSkip to main contentSkip to account menu

Choline Fenofibrate

A choline formulation of fenofibrate, a synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVE The objective of this study was to evaluate the pharmacokinetics and bioequivalence of two formulations (the original… 
2019
2019
Familial combined hyperlipoproteinemia is considered one of the most common genetic hyperlipidemias in the general population… 
2016
2016
The purpose of this study is to investigate the effects of formulation on the swelling behavior of choline fenofibrate hydrogel… 
2016
2016
The invention discloses a preparation method of a choline fenofibrate acid sustained release capsule.The preparation method of… 
2015
2015
The objective of the current study was to develop a simple, accurate, precise and rapid RP-HPLC method And subsequently validate… 
2015
2015
Background: Fibrates are the most efficient drugs to decrease serum triglycerides (TG). Several formulations of fenofibrate have… 
2009
2009
(-)-Gossypol; Abacavir sulfate/lamivudine, ACAM-1000, ACE-011, Agomelatine, AGS-004, Alemtuzumab, Alvocidib hydrochloride, AMG… 
2009
2009
(+)-Dapoxetine hydrochloride, [(123)I]-BZA, 9-Aminocamptothecin; Abacavir sulfate/lamivudine, Adalimumab, Adefovir dipivoxil… 
2009
2009
[Methoxy-(11)C]PD-153035, 2-Methoxyestradiol; Adalimumab, Adecatumumab, Adefovir dipivoxil, ADH-1, ADX-10059, Aflibercept, AIR…